MIC B12 Compounded Injectable Lacks Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling a lot of MIC B12 25/50/50/1+B6 injectable because the manufacturer cannot assure sterility of the product.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a sterile injectable drug product where sterility cannot be assured. Such products pose a direct risk of serious infection if administered to patients, and the sterility hazard in injectable drugs meets the Severe threshold per the rubric criteria for Class II recalls with significant risk of harm.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling lot 08112021:23 of MIC B12 25/50/50/1+B6 100 MG/ML injectable (with best-use date of 11/09/2021) distributed throughout the United States, including Washington, D.C. and Puerto Rico.
The recall was initiated due to lack of assurance of sterility. Injectable products require strict sterility standards to prevent infection and other serious health complications when administered to patients.
Patients who have received this product should consult their healthcare provider immediately if they experience any signs of infection or adverse health effects. Healthcare providers and patients in possession of this medication should stop using it and contact Vita Pharmacy, LLC dba Talon Compounding Pharmacy for further guidance.
The recalled product
- Product
- MIC B12 25/50/50/1+B6 100 MG/ML INJ INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-assurance
- infection-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 08112021:23 BUD: 11/09/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27